The effect of mesenchymal stromal cells and the mobilization of stem cells in bone marrow on the development of nephrosclerosis
- Authors: Belogorodtsev SN1, Shvarts Y.S.1, Filimonov PN1, Seledtsova GV1, Belogorodtsev SN2, Schvarz Y.S3, Filimonov PN4, Seledtsova GV2
-
Affiliations:
- State Research Institute of Clinical Immunology Siberian Branch of RAMS, Novosibirsk
- State Scientific-Research Institute of Therapy Siberian Branch of RAMS, Novosibirsk
- Novosibirsk Research Institute of Tuberculosis, Novosibirsk
- Issue: Vol 5, No 2 (2010)
- Pages: 68-72
- Section: Articles
- URL: https://genescells.ru/2313-1829/article/view/121481
- DOI: https://doi.org/10.23868/gc121481
- ID: 121481
Cite item
Abstract
About the authors
S N Belogorodtsev
Ya Sh Shvarts
P N Filimonov
G V Seledtsova
S N Belogorodtsev
State Research Institute of Clinical Immunology Siberian Branch of RAMS, NovosibirskState Research Institute of Clinical Immunology Siberian Branch of RAMS, Novosibirsk
Ya S Schvarz
State Scientific-Research Institute of Therapy Siberian Branch of RAMS, NovosibirskState Scientific-Research Institute of Therapy Siberian Branch of RAMS, Novosibirsk
P N Filimonov
Novosibirsk Research Institute of Tuberculosis, NovosibirskNovosibirsk Research Institute of Tuberculosis, Novosibirsk
G V Seledtsova
State Research Institute of Clinical Immunology Siberian Branch of RAMS, NovosibirskState Research Institute of Clinical Immunology Siberian Branch of RAMS, Novosibirsk
References
- Chatziantoniou С, Dussaule J-C. Insight into the mechanisms of renal fibrosis: is it possible to achieve regression? Am. J. Physiol. Renal. Physiol. 20D5; 289: 227-34.
- Yu H.T. Progression ofchronic renal failure. Arch. Intern. Med. 2003; 1B3: 1417-29.
- KisselevaT., Brenner D.A. Mechanisms of fibrogenesis. Exp. Biol. Med. 2008; 233: 109-22.
- Boor P., Sebekova K., Ostendorf Т., Floege J. Treatment target in renal fibrosis. Nephrol. Dial. Transplant. 2007; 22: 3391-407.
- Parmar M.S. Chronic renal disease. BMJ 2002; 325:85-90.
- Togel F., Hu Z., Weis K. et al. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal. Physiol. 2005; 289: 31-42.
- Morigi M., Imberti В., Zola С et al. Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure. J. Am. Soc. Nephrol. 2004; 15: 1794-804.
- Bi В., Schmitt R., Israilova H. et al. Stromal cells protect against acute tubular injury via an endocrine effect. J. Am. Soc. Nephrol. 2007; 18: 2486-96.
- Togel F., Weiss K., Yang Y. et al. Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am. J. Physiol. Renal. Physiol. 2007; 292: 1626-35.
- Morigi M., Introna M., Imberti B. et al. Human bone marrow mesenchymal stem cells accelerate recovery of acute renal injury and prolong survival in mice. Stem Cells 2008; 26: 2075-82.
- H.Herrera M.B., Bussolati В., Bruno S. et al. Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury. Kidney International 2007; 72: 430-41.
- Poulson R., Alison M.A., Cook T. et al. Bone marrow stem cells contribute to healing of the kidney. J. Am. Soc. Nephrol. 2003; 14: 48-54.
- Guo J-K., Schedl A., Krause D.S. Bone marrow transplantation can attenuate the progression of mesangial sclerosis. Stem Cells 2006; 24: 406-15.
- Burne-Taney M.J., Kofler J., Yokota N. et al. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am. J. Physiol. Renal. Physiol. 2003; 285: 87-94.
- Rabb H. Immune modulation of acute kidney injury. J. Am. Soc. Nephrol. 2006; 17: 604-6.
- Jo S-K., Sung S-A., Cho W-Y. et al. Macrophages contribute to the initiation of ischemic acute renal failure in rats. Nephrol. Dial. Transplant. 2006; 21: 1231-9.
- Zager R.A., Johnson A.C.M., Lung S. et al. Acute renal failure: determinants and characteristics of the injury-induced hyperinf lammatory response. Am. J. Physiol. Renal. Physiol. 2006; 291: 546-56.
- Catania J.M., Chen G., Parrish A.R. Role of metalloproteinases in renal pathophisiologies. Am. J. Physiol. Renal. Physiol. 2007; 292: 905-11.
- Nauta A.J., Fibbe W.E. Immunomodulatory properties of mesenchymal stromal sells. Blood 2007; 110: 3499-506.
- Кругляков П.В., Лохматова Е.А., Климович В.В., Зарицкий А.Ю. Мезенхимальные стволовые клетки и иммунопатологические состояния организма. Клеточная трансплантология и тканевая инженерия 2008; 3(5): 36-41.
- Iwasaki М., Adachi Y., Minamino К. et al. Mobilization of bone marrow cells by G-CSF rescues mice from cisplatin-indused renal failure, and M-CSF enhances the effect of G-CSF.J. Am. Soc. Nephrol. 2005: 16: 658-66.
- Togel F., Isaac J., Westenfelder С Hematopoietic stem cell mobilization-associated granulocytosis severely worsens acute renal failure. J. Am. Soc. Nephrol. 2004; 15: 1261-7.
- Stokman G., Leemans J.C., Claessen N., Weening J.J., Florquin S. Hematopoietic stem cell mobilization therapy accelerates recovery of renal function independent of stem cell contribution. J. Am. Soc. Nephrol. 2005; 16: 1684-92.
- Kurtz T.W., Maletz R.M., Hsu C.H. Renal cortical blood flow in glycerol-induced acute renal failure in the rat. Circ. Res. 1976; 38: 30-35.
- Lieberthal W., Nigam S.K. Acute renal failure. II. Experimental models of acute renal failure: imperfect but indispensable. Am. J. Physiol. Renal Physiol. 2000; 278: 1-12.
- Zager R.A., Jonson A.C., Lund S. et al. Acute renal failure: determinants and characteristics of injury-induced hyperinflammatory response. Am. J. Physiol. Renal Physiol. 2006; 291: 546-56.
- Шестобаев Е.Ю., Капля О.А., Зуева Е.П., Разина Т.Г. Функциональная активность перитонеальных макрофагов при развитии карциномы легких Льюс на фоне применения экстракта шлемника байкальского и циклофосфана. Сибирский онкологический журнал 2004; 4: 37-41.